$18.82
0.84% yesterday
Nasdaq, Apr 10, 10:21 pm CET
ISIN
IL0011794802
Symbol
CLBT

Cellebrite DI Target price 2025 - Analyst rating & recommendation

Cellebrite DI Classifications & Recommendation:

Buy
100%

Cellebrite DI Price Target

Target Price $27.57
Price $18.82
Potential
Number of Estimates 7
7 Analysts have issued a price target Cellebrite DI 2026 . The average Cellebrite DI target price is $27.57. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 8 Analysts recommend Cellebrite DI to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cellebrite DI stock has an average upside potential 2026 of . Most analysts recommend the Cellebrite DI stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 401.20 484.16
23.40% 20.68%
EBITDA Margin 16.88% 24.58%
26.78% 45.60%
Net Margin -78.91% 14.51%
154.41% 118.39%

8 Analysts have issued a sales forecast Cellebrite DI 2025 . The average Cellebrite DI sales estimate is

$484m
Unlock
. This is
20.68% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$488m 21.64%
Unlock
, the lowest is
$480m 19.64%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $401m 23.40%
2025
$484m 20.68%
Unlock
2026
$569m 17.61%
Unlock
2027
$669m 17.46%
Unlock
2028
$724m 8.22%
Unlock

7 Analysts have issued an Cellebrite DI EBITDA forecast 2025. The average Cellebrite DI EBITDA estimate is

$119m
Unlock
. This is
75.67% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$121m 79.31%
Unlock
, the lowest is
$113m 66.81%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $67.7m 56.46%
2025
$119m 75.70%
Unlock
2026
$143m 20.45%
Unlock
2027
$173m 20.39%
Unlock
2028
$182m 5.59%
Unlock

EBITDA Margin

2024 16.88% 26.78%
2025
24.58% 45.60%
Unlock
2026
25.17% 2.40%
Unlock
2027
25.80% 2.50%
Unlock
2028
25.17% 2.44%
Unlock

8 Cellebrite DI Analysts have issued a net profit forecast 2025. The average Cellebrite DI net profit estimate is

$70.3m
Unlock
. This is
121.40% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$120m 136.43%
Unlock
, the lowest is
$58.6m 117.86%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-317m 213.95%
2025
$70.3m 122.20%
Unlock
2026
$83.8m 19.28%
Unlock
2027
$108m 29.21%
Unlock
2028
$157m 45.09%
Unlock

Net Margin

2024 -78.91% 154.41%
2025
14.51% 118.39%
Unlock
2026
14.72% 1.45%
Unlock
2027
16.19% 9.99%
Unlock
2028
21.71% 34.10%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.35 0.30
213.95% 122.22%
P/E 62.81
EV/Sales 8.41

8 Analysts have issued a Cellebrite DI forecast for earnings per share. The average Cellebrite DI EPS is

$0.30
Unlock
. This is
121.43% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.51 136.43%
Unlock
, the lowest is
$0.25 117.86%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.35 213.95%
2025
$0.30 122.22%
Unlock
2026
$0.36 20.00%
Unlock
2027
$0.46 27.78%
Unlock
2028
$0.67 45.65%
Unlock

P/E ratio

Current -13.47 31.69%
2025
62.81 566.30%
Unlock
2026
52.65 16.18%
Unlock
2027
40.76 22.58%
Unlock
2028
28.09 31.08%
Unlock

Based on analysts' sales estimates for 2025, the Cellebrite DI stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.15 67.77%
2025
8.41 17.17%
Unlock
2026
7.15 14.97%
Unlock
2027
6.09 14.87%
Unlock
2028
5.62 7.59%
Unlock

P/S ratio

Current 11.23 64.85%
2025
9.31 17.14%
Unlock
2026
7.91 14.97%
Unlock
2027
6.74 14.87%
Unlock
2028
6.23 7.59%
Unlock

Current Cellebrite DI Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
Locked
Locked Apr 02 2025
Needham
Locked
Locked
Locked Mar 27 2025
Needham
Locked
Locked
Locked Mar 10 2025
Lake Street
Locked
Locked
Locked Feb 14 2025
Needham
Locked
Locked
Locked Feb 14 2025
JP Morgan
Locked
Locked
Locked Feb 11 2025
Needham
Locked
Locked
Locked Jan 22 2025
Analyst Rating Date
Locked
Needham:
Locked
Locked
Apr 02 2025
Locked
Needham:
Locked
Locked
Mar 27 2025
Locked
Needham:
Locked
Locked
Mar 10 2025
Locked
Lake Street:
Locked
Locked
Feb 14 2025
Locked
Needham:
Locked
Locked
Feb 14 2025
Locked
JP Morgan:
Locked
Locked
Feb 11 2025
Locked
Needham:
Locked
Locked
Jan 22 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today